Bristol Myers Squibb Receives European Commission Approval for Opdivo® (Nivolumab) in Combination With Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients With Unresectable or Metastatic Urothelial Carcinoma
$Tesla(TSLA.US$ Tesla too much tease la